Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microplasmin intravitreal injection for non-surgical PVD induction in vitreomacular traction
2006-006085-42Phase 2Completed
- Sponsor
- Oxurion
- Start
- Jan 2007
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ocriplasmin in vitreomacular traction (VMT) (5 arms), sponsored by Oxurion. Started Jan 2007; status: completed.
02
Drugs
ocriplasmin
03
Conditions
vitreomacular traction (VMT)
Beyond the preview
Go deeper on 2006-006085-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006085-42.